Literature DB >> 24222599

Mass spectrometric characterization of a series of adenosylated peptides acting as bisubstrate analogs of protein kinases.

B W Gibson1, D Medzihradszky, W M Hines, S Auriola, G L Kenyon.   

Abstract

We are currently developing strategies to synthesize bisubstrate analogs as potential inhibitors of serine and tyrosine protein kinases; several such analogs have been synthesized. The initial target proteins were the cAMP dependent protein kinase (cAPK) and the Ca(+2)/calmodulin dependent protein kinase (CaM kiiase II). These bisubstrate analogs were based on either known peptide substrates such as kemptide, a seven amino acid peptide substrate of cAPK, or on inhibitory peptides such as a seventeen amino acid peptide encompassing the autoinhibitory domain of CaM kinase II. Peptides containing a single phosphoserine group were first synthesized and then adenosine 5'-monophosphate (AMP), adenosine 5'-diphosphate (ADP), or adenosine 5'-triphosphate (ATP) was coupled through the serine phosphate with prior activation by 1,1-carbonyldiimidazole using either a solution or solid phase reaction scheme. In this current study, we report the characterization of the bisubstrate analogs by liquid secondary ionization mass spectrometry (LSIMS), matrix-assisted laser desorption mass spectrometry (MALDI), and tandem mass spectrometry (MS/MS).In the positive-ion mode, the LSIMS spectra of the bisubstrate analogs yielded a series of molecular ions containing mono-, di-, and trivalent cation adducts. Cation adducts were absent in the negative-ion mode where the dominant species were deprotonated molecular ions, [M - H](-), making this latter technique more useful for confirming product identity and assessing purity. Analysis of these compounds by MALDI in both the positive- and negative-ion modes yielded molecular ions which also contained metal ion adducts, although they were limited primarily to Fe(+2) adducts. Unlike LSIMS, the MALDI spectra showed no evidence for the elimination of the phosphoadenosine or other structural moieties. When these compounds were subjected to high energy collision-induced dissociation (CID), the dominant fragmentation pathways under positive-ion MS/MS conditions resulted from cleavage of the phosphate linkages to the adenosine moiety with charge retention on the peptide, although a major peak for 5'-deoxyadenosine was also seen at m/z 250. Charge retention in the negative-ion mode was most pronounced for ion fragments containing the highly acidic phosphate moieties and yielded phosphoadenosine related ions, for example, (AMP-H)(-), (AMP-H-H2O)(-), (ADP-H)(-), etc., as well as ions originating from the phosphate linker such as PO3 (-), H2PO4 (-), HP2O6 (-), H3P2O7 (-), and H2P3O9 (-). The largest phosphoadenosine ion in the negative-ion CID spectra for each bisubstrate analog, for example, m/z 426 (ADP-H)(-), m/z 506 (ATP-H)(-), or m/z 586 (AP4-H)(-), indicated that the desired covalent modification had been formed between the phosphoserine and APn moieties.

Entities:  

Year:  1994        PMID: 24222599     DOI: 10.1016/1044-0305(94)85060-7

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  31 in total

1.  Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; D J Graves; E Benjamini; E G Krebs
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  Selective detection of phosphopeptides in complex mixtures by electrospray liquid chromatography/mass spectrometry.

Authors:  M J Huddleston; R S Annan; M F Bean; S A Carr
Journal:  J Am Soc Mass Spectrom       Date:  1993-09       Impact factor: 3.109

3.  Ion source for liquid matrix secondary ionization mass spectrometry.

Authors:  A M Falick; G H Wang; F C Walls
Journal:  Anal Chem       Date:  1986-06       Impact factor: 6.986

4.  Analysis of the in vivo phosphorylation state of rabbit skeletal muscle glycogen synthase by fast-atom-bombardment mass spectrometry.

Authors:  L Poulter; S G Ang; B W Gibson; D H Williams; C F Holmes; F B Caudwell; J Pitcher; P Cohen
Journal:  Eur J Biochem       Date:  1988-08-15

5.  Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.

Authors:  D Yee; F R Morales; T C Hamilton; D D Von Hoff
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

Review 6.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  A tyrosine-specific protein kinase inhibitor, alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide, blocks the phosphorylation of tyrosine kinase substrate in intact cells.

Authors:  T Shiraishi; M K Owada; M Tatsuka; Y Fuse; K Watanabe; T Kakunaga
Journal:  Jpn J Cancer Res       Date:  1990 Jun-Jul

8.  Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro.

Authors:  T Shiraishi; M K Owada; M Tatsuka; T Yamashita; K Watanabe; T Kakunaga
Journal:  Cancer Res       Date:  1989-05-01       Impact factor: 12.701

9.  Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.

Authors:  Y Yamanaka; H Friess; M S Kobrin; M Buchler; H G Beger; M Korc
Journal:  Anticancer Res       Date:  1993 May-Jun       Impact factor: 2.480

10.  Tandem mass spectrometry reveals that three photosystem II proteins of spinach chloroplasts contain N-acetyl-O-phosphothreonine at their NH2 termini.

Authors:  H Michel; D F Hunt; J Shabanowitz; J Bennett
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

View more
  1 in total

1.  Characterization of AMPylation on threonine, serine, and tyrosine using mass spectrometry.

Authors:  Yan Li; Rowaida Al-Eryani; Melanie L Yarbrough; Kim Orth; Haydn L Ball
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-24       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.